RSS Feed
Twitter
Percutaneous coronary intervention (PCI) remains a widely utilized, aggressive reperfusion strategy for patients with acute coronary syndromes (ACS) - STEMI, NSTEMI and UA. In this primary research piece, Datamonitor shifts away from focus solely on the EU. For the first time, we provide an in-depth comparison of PCI/stent practices between the US and the 5EU markets. Scope
* What are the preferred revascularization strategies and how are these affected by geography and diagnosis?
* To what extent are reperfusion therapies, such as PCI (percutaneous coronary intervention) and/or thrombolysis, used?
* Which are the preferred drug classes used as adjunctive therapies to PCI and to what extent are they used?
* What are the current hospital admission and logistics issues? Highlights Revascularization patterns vary and are dependent largely on ACS subtype. STEMI patients in all countries showed greater use of thrombolytics compared to NSTEMI and UA patients. PCI represents a more aggressive method to reopen coronary vessels. PCI is widely used in all ACS patients, but is most common in STEMI, particularly in Germany and the US. Time-to-PCI is very important for myocardial salvage. Germany, followed by the US, showed the highest proportion of STEMI and NSTEMI patients achieving symptom onset to PCI time and door to PCI times in less than 12 hours. This is a function of Germany’s excellent PCI infrastructure. There is wide regional variation in the use of bare metal stents and drug-eluting stents. Germany and France show preference for BMS over DES in all ACS types. Additional data and newly available stents, have powered a shift in practice back towards use of DES, particularly in Italy, Spain, UK and the US. Reasons to Purchase * Understand the PCI market, the driving indications and the drug classes prescribed in PCI patients.
* Gain access to patient records reflecting the current clinical practice in the US and the EU.
* Identify underserved areas in both terms of geography and diagnosis. Get more information about this report: Stakeholder Insight: Percutaneous Coronary Intervention - A comparison between US and EU practice Find Market Research Reports Check our Company Profiles and Country Reports Bharat Book Bureau
Email: sandhya@bharatbook.com
Tel: +91 22 27578668
Fax: +91 22 27579131
* What are the preferred revascularization strategies and how are these affected by geography and diagnosis?
* To what extent are reperfusion therapies, such as PCI (percutaneous coronary intervention) and/or thrombolysis, used?
* Which are the preferred drug classes used as adjunctive therapies to PCI and to what extent are they used?
* What are the current hospital admission and logistics issues? Highlights Revascularization patterns vary and are dependent largely on ACS subtype. STEMI patients in all countries showed greater use of thrombolytics compared to NSTEMI and UA patients. PCI represents a more aggressive method to reopen coronary vessels. PCI is widely used in all ACS patients, but is most common in STEMI, particularly in Germany and the US. Time-to-PCI is very important for myocardial salvage. Germany, followed by the US, showed the highest proportion of STEMI and NSTEMI patients achieving symptom onset to PCI time and door to PCI times in less than 12 hours. This is a function of Germany’s excellent PCI infrastructure. There is wide regional variation in the use of bare metal stents and drug-eluting stents. Germany and France show preference for BMS over DES in all ACS types. Additional data and newly available stents, have powered a shift in practice back towards use of DES, particularly in Italy, Spain, UK and the US. Reasons to Purchase * Understand the PCI market, the driving indications and the drug classes prescribed in PCI patients.
* Gain access to patient records reflecting the current clinical practice in the US and the EU.
* Identify underserved areas in both terms of geography and diagnosis. Get more information about this report: Stakeholder Insight: Percutaneous Coronary Intervention - A comparison between US and EU practice Find Market Research Reports Check our Company Profiles and Country Reports Bharat Book Bureau
Email: sandhya@bharatbook.com
Tel: +91 22 27578668
Fax: +91 22 27579131
via Posterize
Posts
0 comments:
Post a Comment